Emily Hill's most recent trade in Replimune Group Inc was a trade of 2,535 Common Stock done at an average price of $8.1 . Disclosure was reported to the exchange on May 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Replimune Group Inc | Emily Hill | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.05 per share. | 20 May 2025 | 2,535 | 143,522 (0%) | 0% | 8.1 | 20,407 | Common Stock |
| Replimune Group Inc | Emily Hill | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 67,500 | 67,500 | - | - | Employee Stock Option (right to buy) | |
| Replimune Group Inc | Emily Hill | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 45,000 | 146,057 (0%) | 0% | 0 | Common Stock | |
| Replimune Group Inc | Emily Hill | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.18 per share. | 16 Aug 2024 | 8,938 | 101,057 (0%) | 0% | 10.2 | 90,989 | Common Stock |
| Beneficient - Ordinary Sha... | Emily B. Hill | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.38 per share. | 07 Jun 2024 | 125 | 1,143 | - | 5.4 | 673 | Class A Common Stock |
| Replimune Group Inc | Emily Hill | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 80,000 | 80,000 | - | - | Employee Stock Option (right to buy) | |
| Replimune Group Inc | Emily Hill | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 26,665 | 109,995 (0%) | 0% | 0 | Common Stock | |
| Beneficient - Ordinary Sha... | Emily B. Hill | Director | 31 Mar 2023 | 643 | 1,268 | - | 0 | Class A Common Stock | ||
| PTC Therapeutics Inc | Emily Hill | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 45.00 per share. | 27 Mar 2023 | 7,363 | 38,925 (0%) | 0% | 45 | 331,335 | Common Stock |
| PTC Therapeutics Inc | Emily Hill | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 45.63 per share. | 31 Jan 2023 | 575 | 46,288 (0%) | 0% | 45.6 | 26,236 | Common Stock |
| PTC Therapeutics Inc | Emily Hill | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 47.45 per share. | 24 Jan 2023 | 223 | 46,863 (0%) | 0% | 47.5 | 10,582 | Common Stock |
| PTC Therapeutics Inc | Emily Hill | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 42.93 per share. | 10 Jan 2023 | 497 | 47,504 (0%) | 0% | 42.9 | 21,338 | Common Stock |
| PTC Therapeutics Inc | Emily Hill | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 44.36 per share. | 10 Jan 2023 | 418 | 47,086 (0%) | 0% | 44.4 | 18,542 | Common Stock |
| PTC Therapeutics Inc | Emily Hill | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 41.66 per share. | 09 Jan 2023 | 758 | 48,001 (0%) | 0% | 41.7 | 31,575 | Common Stock |
| PTC Therapeutics Inc | Emily Hill | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 42,500 | 42,500 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Emily Hill | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 19,500 | 48,759 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Emily Hill | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 37.78 per share. | 31 Mar 2022 | 7,910 | 29,259 (0%) | 0% | 37.8 | 298,824 | Common Stock |
| PTC Therapeutics Inc | Emily Hill | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 01 Feb 2022 | 553 | 37,169 (0%) | 0% | 40.0 | 22,121 | Common Stock |
| PTC Therapeutics Inc | Emily Hill | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 39.31 per share. | 25 Jan 2022 | 211 | 37,722 (0%) | 0% | 39.3 | 8,295 | Common Stock |
| PTC Therapeutics Inc | Emily Hill | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 58,500 | 58,500 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Emily Hill | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 15,600 | 37,933 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Emily Hill | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 38.52 per share. | 07 Jan 2022 | 800 | 22,333 (0%) | 0% | 38.5 | 30,820 | Common Stock |
| PTC Therapeutics Inc | Emily Hill | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 41.16 per share. | 04 Jan 2022 | 173 | 23,133 (0%) | 0% | 41.2 | 7,121 | Common Stock |
| PTC Therapeutics Inc | Emily Hill | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 56.96 per share. | 01 Feb 2021 | 541 | 23,306 (0%) | 0% | 57.0 | 30,813 | Common Stock |
| PTC Therapeutics Inc | Emily Hill | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 62.05 per share. | 25 Jan 2021 | 275 | 23,847 (0%) | 0% | 62.1 | 17,065 | Common Stock |
| PTC Therapeutics Inc | Emily Hill | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 69.75 per share. | 08 Jan 2021 | 10,500 | 24,122 (0%) | 0% | 69.8 | 732,375 | Common Stock |
| PTC Therapeutics Inc | Emily Hill | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.01 per share. | 08 Jan 2021 | 10,500 | 34,622 (0%) | 0% | 18.0 | 189,105 | Common Stock |
| PTC Therapeutics Inc | Emily Hill | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2021 | 10,500 | 3,500 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Emily Hill | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 69.75 per share. | 08 Jan 2021 | 9,278 | 24,122 (0%) | 0% | 69.8 | 647,141 | Common Stock |
| PTC Therapeutics Inc | Emily Hill | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.02 per share. | 08 Jan 2021 | 9,278 | 33,400 (0%) | 0% | 33.0 | 306,360 | Common Stock |
| PTC Therapeutics Inc | Emily Hill | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2021 | 9,278 | 11,932 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Emily Hill | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 69.75 per share. | 08 Jan 2021 | 3,825 | 24,122 (0%) | 0% | 69.8 | 266,794 | Common Stock |
| PTC Therapeutics Inc | Emily Hill | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.23 per share. | 08 Jan 2021 | 3,825 | 27,947 (0%) | 0% | 11.2 | 42,955 | Common Stock |
| PTC Therapeutics Inc | Emily Hill | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2021 | 3,825 | 0 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Emily Hill | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 69.75 per share. | 08 Jan 2021 | 2,430 | 24,122 (0%) | 0% | 69.8 | 169,493 | Common Stock |
| PTC Therapeutics Inc | Emily Hill | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2021 | 2,430 | 0 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Emily Hill | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.86 per share. | 08 Jan 2021 | 2,430 | 26,552 (0%) | 0% | 30.9 | 74,990 | Common Stock |
| PTC Therapeutics Inc | Emily Hill | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 63,000 | 63,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Emily Hill | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 10,800 | 24,122 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Emily Hill | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 62.37 per share. | 05 Jan 2021 | 176 | 13,322 (0%) | 0% | 62.4 | 10,977 | Common Stock |
| PTC Therapeutics Inc | Emily Hill | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 62.37 per share. | 05 Jan 2021 | 112 | 13,498 (0%) | 0% | 62.4 | 6,985 | Common Stock |